Abiopharma

🔍 Kim Hyong (Executive)

Company: Alignment Healthcare, Inc. (ALHC)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 52,972 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 386,105.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents 52,972 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.